Contemporary Management of Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

Identifying key molecular attributes can help in the risk-adapted treatment of Hodgkin lymphoma and chronic lymphocytic leukemia. At JADPRO Live, presenters reviewed best practices for managing patients with the rapidly expanding armamentarium of treatments for these patients.

Detalles Bibliográficos
Autores principales: Kurtin, Sandra E., McNeill, 1)The University of Arizona Cancer Center, Tucson, Arizona; 2)John Theurer Cancer Center, Hackensack, New Jersey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press 2018
Materias:
Meeting Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333556/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333556/

Ejemplares similares